Home

Press Releases

About

Editorial

Advertise

Cookie Policy

Privacy

Contact

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR

SUBSCRIBE

Market Reports

FDA

Executives

Funding

Non Profits

Hospitals

Acquisitions

Health

Biotechnology News Magazine

LG Announces U.S. Launch of CLOi ServeBot, World’s First Service Robot to Achieve UL Certification

Autonomous unit uses multiple cameras and sensors to navigate complex environments, carrying up to 66 pounds of goods on three shelves with up to 11 hours of operation

Share the News

LG Business Solutions USA announced that the LG CLOi ServeBot is coming to the U.S. market in early 2022. Model LDLIM21 is the world’s first commercial service robot earning UL 3300 certification for safe operation in complex commercial environments such as restaurants, retail stores and hotels.

For the first time, U.S. workers will be able to safely use robot assistants that navigate busy environments while carrying up to 66 pounds of food or goods, assisting with employee workloads, enabling better customer service and increasing operational efficiency.

“The LG CLOi ServeBot is truly a breakthrough for all kinds of consumer-focused businesses, from restaurants to retail stores to hotels,” Jeffrey Weiland, B2B robotics team leader at LG Business Solutions USA said. “As the first commercial service robot to receive UL certification for safe operation in consumer environments, the CLOi ServeBot’s semi-autonomous operation offers businesses an effective means to provide enhanced service, while freeing staff to focus on customer relations and build relationships that encourage repeat visits. Whether it’s delivering food from the kitchen to a table or packages from the storage room to the front counter, LG’s CLOi ServeBot can navigate virtually any environment and free up staff to handle direct customer service.”

Offering up to 11 hours of operation on a single charge, the LG CLOi ServeBot features three shelves that can each hold up to 22 pounds (10kg), for a total delivery capacity of 66 pounds. The robot can be programmed for a variety of floor plans, enabling precise multi-point deliveries ranging from densely packed restaurants to sprawling office complexes.

The UL certification is a major step forward for commercial and consumer robots, with UL 3300 signifying a new standard for SCIEE units. Pronounced “sky,” SCIEE stands for Service, Communication, Information, Education and Entertainment. These robots are built to operate in open-world dynamic environments where they perform functional actions beyond monitoring and can adapt in real-time to changes in the environment.

“Achieving the first UL safety certification for a commercial and consumer robot is a significant milestone. LG has a long-term and deep commitment to public safety. The LG CLOi ServeBot achieving UL Listing demonstrates this,” said UL’s Director of Consumer Technology Ibrahim Jilani.  “LG is leading by example for a very important aspect of any market’s maturity, and that is demonstrating product safety due diligence through UL Certification.”

As a cutting-edge product from a leading global electronics company, the LG CLOi ServeBot has undergone extensive development by LG, independent engineering evaluation and testing by UL. Buyers can be confident that the robot will be supported by LG’s world-class customer service for years to come. The cloud-enabled robots will automatically receive free LG software updates upon publishing, ensuring buyers can reap the greatest return from their investment through expanded capabilities and compatibility.

The LG CLOi ServeBot achieves its impressive feats using a bevy of sensors and technologies. Combining data from a LIDAR detector, a 3D camera, a Time of Flight (ToF) sensor and a bumper sensor, it can recognize stationary and moving objects in its path and make real-time adjustments to avoid collisions. Each shelf also has its own ToF sensor, so the robot knows when an item has been removed and it can move on to the next destination. ToF sensors determine how far away objects are by measuring the time it takes a pulse of light to be reflected back, making them useful for both navigation and shelf occupancy detection.

As a customer service assistant, the LG CLOi ServeBot greets each encounter with a friendly face, complete with friendly, cartoon-like eye animations presented on the unit’s top-mounted 9.2-inch touchscreen. Operators can use the intuitive touchscreen interface to adjust designated locations and select different modes, in addition to modifying voice announcements and music played in response to customer interactions. When connected to the business’ wireless network, CLOi ServeBot enables cloud monitoring so users can receive almost instant status updates.

The LG CLOi ServeBot stands 52.7-inches tall, has a footprint of 20.1 by 20.1-inches, can turn on a dime, and features adjustable speed up to one meter per second (up to 2.2 mph). The on-board 23,000 mAh battery provides up to 11 hours of continuous operation and charges from 0-100% in just five hours using a 120V outlet. Each shelf measures 19.7-inches wide by 15.75-inches deep and features a removable placemat for easy cleaning, providing plenty of surface area for multiple items and multi-site deliveries.

Each LG CLOi ServeBot must be pre-programmed with a map of its operating space and destination points, after which it can automatically determine the ideal path for each point-to-point trip and navigate autonomously through dynamic environments and around moving objects.

Initially, the LG CLOi ServeBot will be available exclusively from certified integrators. LG has initiated product training programs with select integrators around the country and will soon expand outreach to interested firms to ensure nationwide availability.

Executives

Intelligent Implants Taps Leading Medical Device Entrepreneur, Benjamin A. Hertzog, PhD, as CEO

Dr. Hertzog will lead the progression of product development, clinical, and commercial activities for the company’s novel and proprietary smart orthopedic implant platform.

US Med-Equip Appoints 4 New Chief Executives

"We sought out superstars and brought in the best executives in their fields to join our burgeoning team. They will be instrumental in building on the growth of our company and our community of employees and healthcare partners we support," Salario said. Read who they are.

Perineologic Appoints Jim Fortune as President and Promotes Matthew Allaway, DO, to Chief Executive Officer

Mr. Fortune served as chief operating officer at Ocular Therapeutix, Inc. Dr. Allaway is the founder of Perineologic and has been a practicing urologist and managing partner at Urology Associates in Cumberland, Maryland.

FDA Updates

Medtronic Reports FDA Approval of Spinal Cord Stimulation Therapy for Treating Chronic Pain Resulting from Diabetic Peripheral Neuropathy

This new indication enables us to apply Medtronic's more than 40 years of proven SCS experience, as well as the company's deep diabetes expertise, to deliver better care to even greater numbers of diabetes patients.

Cardiovascular Systems, Inc. and OrbusNeich Announce FDA PMA Approval of Scoreflex® Scoring Balloon

Scott Ward, CSI’s Chairman, President and Chief Executive Officer, said, “We remain committed to expanding our portfolio of differentiated products that help physicians deliver improved outcomes for patients with complex coronary artery disease.

Nevro Reports FDA Approval for Expanded Labeling for Senza® Spinal Cord Stimulation System

This approval is specific to Nevro's proprietary 10 kHz Therapy and differentiates Nevro's Senza System as the only SCS system with specific labeling to treat NSRBP patients.
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.
Tags

Diagnostic Imaging

Carestream Continues Drive to Improve Image Quality and Workflow With 45 Patents in 2021

“Carestream continuously strives to deliver cutting-edge technologies worldwide, and these patents demonstrate our commitment to meet the evolving needs of providers and patients alike,” said Eugene Shkurko, Intellectual Property Counsel at Carestream.

Aidoc Partners with Novant Health

By incorporating Aidoc's AI platform, which includes seven FDA-cleared solutions for triage and notification of patients with acute medical conditions, Novant Health is taking proactive steps to improve patient outcomes and reduce emergency department (ED) length of stay amid resource constraints inflicted by the Omicron variant.

Trials

NEJM: New Data on COVID-19 Lung Transplants

The analysis of more than 3,000 lung transplants in the U.S. between Aug. 1, 2020, and Sept. 30, 2021, showed that during the pandemic, 7% of the nation’s lung transplants were performed to treat severe, irreversible lung damage caused by COVID-19. More than half of these patients needed ventilators or extracorporeal membrane oxygenation, or ECMO, before their transplant.

Preclinical Study Provides Guidance for Optimizing Safety and Efficacy of Endovascular Hepatic Denervation Devices to Treat Diabetes

“This study leveraged our deep experience in preclinical evaluation of denervation therapies and could not have been performed in a timely manner without the digital morphometry techniques we developed in-house. We remain excited about the potential of neuromodulation technologies and are committed to supporting further innovation in this space,” explained Rami Tzafriri, PhD, lead author and Director of Research and Innovation at CBSET.

Other News

NEJM: New Data on COVID-19 Lung Transplants

The analysis of more than 3,000 lung transplants in the U.S. between Aug. 1, 2020, and Sept. 30, 2021, showed that during the pandemic, 7% of the nation’s lung transplants were performed to treat severe, irreversible lung damage caused by COVID-19. More than half of these patients needed ventilators or extracorporeal membrane oxygenation, or ECMO, before their transplant.

University of Colorado School of Medicine Will Work with DreaMed Diabetes to Deploy Its Advisor System as a New Resource for Diabetes Device Initiation

“We are truly honored to be part of this project,” said Ryan Hovey, general manager for North America at DreaMed. “We have been able to demonstrate the ability to support endocrinology practices by centralizing patient device data as well as providing evaluation reports and FDA cleared treatment recommendations.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Subscribe to Medical Device News Magazine